β-blockers in advanced cirrhosis: More friend than enemy
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
Clin Mol Hepatol. 2021;27(3):425-436.   Published online 2020 Dec 3     DOI: https://doi.org/10.3350/cmh.2020.0234
Citations to this article as recorded by Crossref logo
Cardiomyopathy in cirrhosis: From pathophysiology to clinical care
Hongqun Liu, Jwan A. Naser, Grace Lin, Samuel S. Lee
JHEP Reports.2024; 6(1): 100911.     CrossRef
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities
Hongqun Liu, Daegon Ryu, Sangyoun Hwang, Samuel S. Lee
International Journal of Molecular Sciences.2024; 25(11): 5849.     CrossRef
Novel approaches in the medical management of compensated cirrhosis
Antonio Moreno-Loro, Álvaro Giráldez, Fernando Jiménez, Ignacio López-Bueno, Alberto Pérez-Ramírez, Manuel Romero-Gómez
Expert Review of Gastroenterology & Hepatology.2024; 18(6): 239.     CrossRef
Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko
GASTROENTEROLOGY.2024; 58(2): 151.     CrossRef
Microarray analysis demonstrates up-regulation of the endothelin-1 gene with compensatory down-regulation of the ETA receptor gene in human portal vein
Nicola E. Owen, Thomas L. Williams, Janet J. Maguire, Rhoda E. Kuc, Emma E. Davenport, Anthony P. Davenport
Bioscience Reports.2024;[Epub]     CrossRef
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension
Bert Vandenberk, Mario H. Altieri, Hongqun Liu, Satish R. Raj, Samuel S. Lee
Alimentary Pharmacology & Therapeutics.2023; 57(3): 290.     CrossRef
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clinical and Molecular Hepatology.2023; 29(1): 105.     CrossRef
Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
Clinical and Molecular Hepatology.2023; 29(1): 188.     CrossRef
Potential therapies for acute‐on‐chronic liver failure
Maura A. Morrison, Florent Artru, Francesca M. Trovato, Evangelos Triantafyllou, Mark J. McPhail
Liver International.2023;[Epub]     CrossRef
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(8): 1372.     CrossRef
Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy
Sang Youn Hwang, Hongqun Liu, Samuel S. Lee
Biomedicines.2023; 11(7): 1895.     CrossRef
How to suspect the presence of high‐risk esophageal varices and when to start endoscopic surveillance in children with biliary atresia?
Ujjal Poddar, Arghya Samanta, Moinak Sen Sarma, Basant Kumar, Richa Lal, Anshu Srivastava, Vijay Datta Upadhyaya, Surender Kumar Yachha, Ankur Mandelia
Journal of Gastroenterology and Hepatology.2023; 38(9): 1610.     CrossRef
Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy
Hongqun Liu, Sang-Youn Hwang, Samuel S. Lee
Pharmaceuticals.2023; 16(7): 978.     CrossRef
Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
Xinyi He, Zimo Zhao, Xi Jiang, Yan Sun
Frontiers in Pharmacology.2023;[Epub]     CrossRef
Portal vein thrombosis in cirrhosis: exploring the uncharted waters
P Anirvan
Journal of Gastroenterology and Hepatology.2023; 38(10): 1855.     CrossRef
MicroRNAs as critical regulators in liver fibrosis
Xiaolin Wang, Qiuhong Zai, Yong He, Qing Xie
Portal Hypertension & Cirrhosis.2023; 2(3): 144.     CrossRef
The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status
Josip Stojic, Michał Kukla, Ivica Grgurevic
Diagnostics.2023; 13(18): 2960.     CrossRef
Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis
Mason Lai, Cynthia Fenton, Jin Ge, Jessica Rubin, Jennifer C. Lai, Giuseppe Cullaro
Hepatology Communications.2023;[Epub]     CrossRef
Hepatorenal syndrome: Current concepts and future perspectives
Chan-Young Jung, Jai Won Chang
Clinical and Molecular Hepatology.2023; 29(4): 891.     CrossRef
In severe alcohol‐related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL‐8 and micro‐RNAs
Luke D. Tyson, Stephen Atkinson, Robert W. Hunter, Michael Allison, Andrew Austin, James W. Dear, Ewan Forrest, Tong Liu, Emma Lord, Steven Masson, Joao Nunes, Paul Richardson, Stephen D. Ryder, Mark Wright, Mark Thursz, Nikhil Vergis
Alimentary Pharmacology & Therapeutics.2023; 58(11-12): 1217.     CrossRef
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao
Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascites
Jim Höppner, Sandra Krohn, Ellen H. A. van den Munckhof, René Kallies, Adam Herber, Katharina Zeller, Jan Tünnemann, Madlen Matz-Soja, Antonis Chatzinotas, Stephan Böhm, Albrecht Hoffmeister, Thomas Berg, Cornelius Engelmann
Scientific Reports.2023;[Epub]     CrossRef
Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clinical and Molecular Hepatology.2022; 28(1): 31.     CrossRef
Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy
Hongqun Liu, Henry H. Nguyen, Ki Tae Yoon, Samuel S. Lee
Frontiers in Network Physiology.2022;[Epub]     CrossRef
Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database
Hankil Lee, Beom Kyung Kim
Journal of Gastroenterology and Hepatology.2022; 37(11): 2154.     CrossRef
Prolonged QT Interval in Cirrhosis: Twisting Time?
William Lee, Bert Vandenberk, Satish R. Raj, Samuel S. Lee
Gut and Liver.2022; 16(6): 849.     CrossRef
New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
Hankil Lee, Jeong-Ju Yoo, Sang Hoon Ahn, Beom Kyung Kim
Clinical and Translational Gastroenterology.2022; 13(12): e00542.     CrossRef
Advances in cirrhotic cardiomyopathy
Hongqun Liu, Ki Tae Yoon, Jing Zhang, Samuel S. Lee
Current Opinion in Gastroenterology.2021; 37(3): 187.     CrossRef